drugs

After a Point-Blank Rejection Letter From the FDA, This Founder Went Back to the Drawing Board

Cindy Whitehead spent years working on a treatment for low sexual desire in women. When the FDA rejected her drug, she disputed the decision with the stories of affected women -- and won.

Hayden Field

· 7 min read

Get Ready for Digital Pills: FDA Clears Self-Tracking Drug

The drug, which contains a tiny ingestible sensor, is designed for patients with mental illness.

Michael Kan

· 3 min read

GameStop Sells (Another) Used Game Containing Bag of Meth

GameStop really needs to review its used game checking policy, as this is the second time meth has been discovered inside a game case.

Matthew Humphries

· 2 min read

The Real Risk of Entrepreneurial Strengths Becoming Addictive Weaknesses

The willfulness and comfort with risk that makes an entrepreneur bold in business can morph into recklessness when they enter a casino or a bar.

Marvin Dumont

· 5 min read

Amid EpiPen Furor, a CEO Shows How Not to Swim Against the Tide

Mylan's crisis response to high EpiPen prices is focused on an important goal: changing the national conversation on health pricing.

Ray Hennessey

· 6 min read

6 Traits Costa Rican Drug Dealers and Successful Entrepreneurs Have in Common

Maybe it's time to get serious about wearing a fanny pack.

Andrew Medal

· 4 min read

The FDA Wants to Find Out if Cartoon Drug Ads Are Bad for Consumers

The agency will look into whether the ads obscure important safety and side effect information.

Sy Mukherjee

· 3 min read

Pfizer to Buy Botox Maker Allergan in Massive $160 Billion Deal

The acquisition will create the world's largest drugmaker.

Reuters

· 4 min read

Two Men Accused of Using Taco Bell as a Meth Lab

Some off-menu items were allegedly being cooked up at this fast-food joint.

Kate Taylor

· 1 min read

Ebola Vaccine Shown to Be 'Highly Effective'

Interim analysis of a trial to protect against the deadly disease has been shown to, thus far, be successful.

Catherine Clifford

· 2 min read